BR0211173A - Formulação galênica injetável para utilização em um diagnóstico ou em uma terapia fotodinâmica e processo de preparação da mesma - Google Patents
Formulação galênica injetável para utilização em um diagnóstico ou em uma terapia fotodinâmica e processo de preparação da mesmaInfo
- Publication number
- BR0211173A BR0211173A BR0211173-0A BR0211173A BR0211173A BR 0211173 A BR0211173 A BR 0211173A BR 0211173 A BR0211173 A BR 0211173A BR 0211173 A BR0211173 A BR 0211173A
- Authority
- BR
- Brazil
- Prior art keywords
- diagnosis
- preparation process
- photodynamic therapy
- formulation
- galenic formulation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000009472 formulation Methods 0.000 title abstract 5
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 238000002428 photodynamic therapy Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- 239000003504 photosensitizing agent Substances 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal salt Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
"FORMULAçãO GALêNICA INJETáVEL PARA UTILIZAçãO EM UM DIAGNóSTICO OU EM UMA TERAPIA FOTODINâMICA E PROCESSO DE PREPARAçãO DA MESMA". Descreve-se uma formulação galênica injetável para a utilização em um diagnóstico ou em uma terapia fotodinâmica (PDT) e o seu processo de preparação. A formulação contém: um composto representado pela fórmula geral (I) a seguir: na qual R~ 2~ representa um grupo H, OH ou COOR~ 4~, em que R~ 4~ é um hidrogênio ou um alquila em C~ 1~-C~ 12~ ou um cicloalquila em C~ 3~-C~ 12~, R~ 3~ representa H, OH ou um alquila ou alcóxi em C~ 1~C~ 12~ e * representa um carbono assimétrico sob a forma de um sal de metal alcalino, em uma quantidade que não ultrapassa 10 mg/ml, como agente fotossensibilizador e um veículo em fase aquosa que contém pelo menos uma mistura de álcool benzílico - etanol ou propileno glicol como agente de solubilização do agente fotossensibilizador e um tensoativo em uma quantidade que não ultrapassa 20% em peso em relação ao peso total da formulação.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01810708A EP1277470A1 (fr) | 2001-07-17 | 2001-07-17 | Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation |
PCT/IB2002/002661 WO2003009842A1 (fr) | 2001-07-17 | 2002-07-05 | Formulation galenique injectable pour utilisation dan un diagnostic ou une therapie photodynamique et son procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211173A true BR0211173A (pt) | 2004-08-10 |
Family
ID=8184036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211173-0A BR0211173A (pt) | 2001-07-17 | 2002-07-05 | Formulação galênica injetável para utilização em um diagnóstico ou em uma terapia fotodinâmica e processo de preparação da mesma |
Country Status (20)
Country | Link |
---|---|
US (1) | US20040147500A1 (pt) |
EP (2) | EP1277470A1 (pt) |
JP (1) | JP2004537562A (pt) |
CN (1) | CN1303999C (pt) |
AT (1) | ATE372769T1 (pt) |
BR (1) | BR0211173A (pt) |
CA (1) | CA2454150A1 (pt) |
DE (1) | DE60222421T2 (pt) |
DK (1) | DK1406616T3 (pt) |
ES (1) | ES2292781T3 (pt) |
HU (1) | HUP0400754A3 (pt) |
IL (1) | IL159620A0 (pt) |
MX (1) | MXPA04000042A (pt) |
NO (1) | NO20040216L (pt) |
NZ (1) | NZ530634A (pt) |
PL (1) | PL368503A1 (pt) |
PT (1) | PT1406616E (pt) |
RU (1) | RU2278665C2 (pt) |
WO (1) | WO2003009842A1 (pt) |
ZA (1) | ZA200400328B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7825153B2 (en) * | 2004-08-16 | 2010-11-02 | Ceramoptec Industries, Inc. | Photosensitizer formulations and their use |
KR100866728B1 (ko) * | 2004-11-12 | 2008-11-03 | 주식회사종근당 | 타크로리무스를 함유하는 주사제 |
EP2008665A1 (fr) * | 2007-06-25 | 2008-12-31 | Steba Biotech N.V. | Formulation injectable pour thérapie photodynamique |
RU2565766C1 (ru) * | 2014-11-17 | 2015-10-20 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Л. Гольдберга" | 4-(3,4-дибромтиофенкарбонил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекан в качестве анальгетического средства и способ его получения |
PT3225112T (pt) * | 2016-04-01 | 2021-09-16 | Trioptotec Gmbh | Dispersão de fotossensibilizador e utilização da mesma |
CN108670950B (zh) * | 2018-06-29 | 2020-10-02 | 深圳海王医药科技研究院有限公司 | 一种不含有机溶剂的虎杖苷药物组合物及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2963178B2 (ja) * | 1990-09-27 | 1999-10-12 | 株式会社エス・エル・ティ・ジャパン | 水溶性フェオホーバイドaの製造方法 |
US5654423A (en) * | 1990-11-21 | 1997-08-05 | Regents Of The University Of California | Boronated metalloporphyrine and therapeutic methods |
JPH08505054A (ja) * | 1992-12-23 | 1996-06-04 | アイオア ステート ユニバーシティー リサーチ ファンデーション インコーポレーテッド | 分子フラッシュ |
US6147195A (en) * | 1993-07-26 | 2000-11-14 | Yeda Research And Development Co., Ltd. | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
US5462726A (en) * | 1993-12-17 | 1995-10-31 | Bristol-Myers Squibb Company | Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents |
US5616342A (en) * | 1995-04-11 | 1997-04-01 | Pdt, Inc. | Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
IL116126A0 (en) * | 1995-11-24 | 1996-01-31 | Yeda Res & Dev | Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them |
ES2277454T3 (es) * | 1998-12-09 | 2007-07-01 | Yeda Research And Development Co. Ltd. | Derivados de bacterioclorofila sustituidos con paladio y uso de los mismos. |
-
2001
- 2001-07-17 EP EP01810708A patent/EP1277470A1/fr not_active Withdrawn
-
2002
- 2002-07-05 HU HU0400754A patent/HUP0400754A3/hu unknown
- 2002-07-05 IL IL15962002A patent/IL159620A0/xx unknown
- 2002-07-05 DK DK02747627T patent/DK1406616T3/da active
- 2002-07-05 NZ NZ530634A patent/NZ530634A/en unknown
- 2002-07-05 JP JP2003515235A patent/JP2004537562A/ja active Pending
- 2002-07-05 CN CNB028142918A patent/CN1303999C/zh not_active Expired - Fee Related
- 2002-07-05 RU RU2004104469/15A patent/RU2278665C2/ru not_active IP Right Cessation
- 2002-07-05 US US10/484,154 patent/US20040147500A1/en not_active Abandoned
- 2002-07-05 PL PL02368503A patent/PL368503A1/xx unknown
- 2002-07-05 PT PT02747627T patent/PT1406616E/pt unknown
- 2002-07-05 CA CA002454150A patent/CA2454150A1/fr not_active Abandoned
- 2002-07-05 EP EP02747627A patent/EP1406616B1/fr not_active Expired - Lifetime
- 2002-07-05 DE DE60222421T patent/DE60222421T2/de not_active Expired - Fee Related
- 2002-07-05 ES ES02747627T patent/ES2292781T3/es not_active Expired - Lifetime
- 2002-07-05 AT AT02747627T patent/ATE372769T1/de not_active IP Right Cessation
- 2002-07-05 MX MXPA04000042A patent/MXPA04000042A/es active IP Right Grant
- 2002-07-05 BR BR0211173-0A patent/BR0211173A/pt not_active IP Right Cessation
- 2002-07-05 WO PCT/IB2002/002661 patent/WO2003009842A1/fr active IP Right Grant
-
2004
- 2004-01-15 ZA ZA200400328A patent/ZA200400328B/en unknown
- 2004-01-16 NO NO20040216A patent/NO20040216L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT1406616E (pt) | 2007-12-20 |
HUP0400754A3 (en) | 2005-11-28 |
EP1277470A1 (fr) | 2003-01-22 |
DK1406616T3 (da) | 2008-01-21 |
EP1406616B1 (fr) | 2007-09-12 |
WO2003009842A8 (fr) | 2004-04-01 |
EP1406616A1 (fr) | 2004-04-14 |
CN1529594A (zh) | 2004-09-15 |
NO20040216L (no) | 2004-03-17 |
JP2004537562A (ja) | 2004-12-16 |
NZ530634A (en) | 2006-11-30 |
MXPA04000042A (es) | 2005-08-16 |
ZA200400328B (en) | 2004-09-13 |
CA2454150A1 (fr) | 2003-02-06 |
CN1303999C (zh) | 2007-03-14 |
ATE372769T1 (de) | 2007-09-15 |
RU2004104469A (ru) | 2005-04-20 |
DE60222421T2 (de) | 2008-06-05 |
US20040147500A1 (en) | 2004-07-29 |
RU2278665C2 (ru) | 2006-06-27 |
HUP0400754A2 (hu) | 2004-07-28 |
DE60222421D1 (de) | 2007-10-25 |
IL159620A0 (en) | 2004-06-01 |
WO2003009842A1 (fr) | 2003-02-06 |
ES2292781T3 (es) | 2008-03-16 |
PL368503A1 (en) | 2005-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0212172A8 (pt) | agente fotossensibilizante ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso do dito agente ou de um sal farmaceuticamente aceitável do mesmo, método para a introdução de uma molécula de transferência no citosol de uma célula, método para tratamento fotoquimioterapêutico de distúrbios ou anormalidades de superfícies externas ou internas do corpo, produto, kit para uso em fotoquimioterapia de distúbios ou anormalidades de superfícies externas ou internas do corpo, e, método para diagnose in vitro de anormalidades ou distúrbios através da análise de uma amostra do fluido do corpo ou do tecido de um paciente | |
BRPI0511036A (pt) | formulações de solução farmacêuticas contendo 17-aag | |
HRP20150957T1 (hr) | Topiäśka kompozicija za uporabu u lijeäśenju rosaceom induciranog crvenila | |
KR890000098A (ko) | 세포 및 조직 수복제 | |
AR011846A1 (es) | Una composicion farmaceutica, y el procedimiento para prepararla | |
BR0314761A (pt) | Composto de adenina e seu uso | |
CO5050325A1 (es) | Composiciones que contienen acidos difosfonicos | |
US5219880A (en) | Treatment of viral tumors and hemorrhoids with artemisinin and derivatives | |
BR0211173A (pt) | Formulação galênica injetável para utilização em um diagnóstico ou em uma terapia fotodinâmica e processo de preparação da mesma | |
CA2399405C (en) | 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents | |
ATE156119T1 (de) | 2-formylpyridin-thiosemicarbazonderivate, ihre herstellung und ihre verwendung als antitumor mittel | |
BR9916845A (pt) | Compostos de (aminoiminometil ouaminometil)benzo-heteroarila substituìdos | |
BRPI0409413A (pt) | composição farmacêutica, uso de um ácido ou sal biliar não conjugado, e, métodos para intensificar a absorção de um princìpio macromolecular ativo em um pacinete e para tratar um paciente que esteja sofrendo de uma condição ou doença tratável | |
KR960007538A (ko) | 알킬벤조일구아니딘 유도체 | |
BR9811843A (pt) | Sistema de agente de consevação para produtos de tratamento corporal | |
HUP9801712A2 (hu) | Racemizálás ellen stabilizált, cilansetrontartalmú gyógyászati készítmények, előállításuk és a stabilizáló adalékanyagok alkalmazása | |
GB2094142A (en) | Injectable solution containing theophylline and a basic amino acid | |
KR880002518A (ko) | 소염제 조성물 | |
BR0314651A (pt) | Composição farmacêutica, e, método para tratar infecção pelo hvi | |
FI946057A (fi) | Paikalliseen käyttöön tarkoitettu valmiste | |
BR9917315A (pt) | Composições medicinais para liberação imediata para uso oral | |
DK166754B1 (da) | Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid | |
BR0208412A (pt) | Agente terapêutico para a hipersensibilidade da bexiga, uso de um composto tricìclico ou de seu sal farmaceuticamente aceitável, e, método para tratar a hipersensibilidade da bexiga | |
BR0202419A (pt) | Compostos de 3-fenil-3,7-diazabiciclo[3,3,1]nonano, bem como processo para a sua preparação e medicamento contendo estes compostos | |
FR2766184B1 (fr) | Medicaments contenant en tant que principe actif au moins un derive de polyhydroxylalkylpyrazine, les nouveaux derives de polyhydroxylalkylpyrazine et leur preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A A NUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |